We’re thrilled to welcome @JaneSparking as General Partner at YZi Labs to lead biotech investments while contributing to our broader AI and Web3 strategy. Since graduating from Stanford GSB, Jane has a strong track record in biotech and medtech, actively pursuing disruptive opportunities at the intersection of AI and biotech. Her expertise spans cancer therapies, gene editing, metabolic treatments, and AI-driven biotech solutions, bringing a visionary approach to investing. Biotech is at the forefront of scientific innovation and is set to transform a broader range of human experiences—from life-saving treatments to AI-driven medical breakthroughs. Jane’s appointment reflects YZi Labs’ deep commitment to backing this transformative sector and the founders driving it forward. She joins @cz_binance @ellazhang516 @danabuidl @odagius @The_Babylonians @mc_9393 @p2fp2e @cyodyssey on the YZi Labs team. Read more in the article below 👇 As our investment focus grows, our mission remains the same: backing visionary founders focused on long-term impact, regardless of market cycles. If you're a founder pushing the boundaries of innovation in Web3, AI, or biotech, apply to work with us at http://bit.ly/YZiLabs 📩